SHORTCAST: Accurate prediction of vaccine candidates using a novel HLA-peptide-TCR-binding tool: OncopeptVAC™ and their validation by OncoPeptSCRN

During this webcast the speaker will address:

  • Challenges in accurate prediction of immunogenic neoantigens
  • Benefits of the OncoPeptVAC platform
  • Assay for immunogenicity of peptides predicted using OncoPeptVAC using OncoPeptSCRN
  • Insights into the discoveries made possible using OncoPeptVAC in combination with OncoPeptSCRN & TCR repertoire assays
  • Benefits of TCR repertoire profiling to assay for immunogenicity


Foster City, CA 94404, USA


Considering Genomic Research?

    Fields marked in * is mandatory to fill

    2024 © MedGenome • All Rights Reserved
    Request a Quote